In this study the authors investigated the ability of hyaluronan (HA) a component of the extracellular matrix (ECM) and its major surface receptor CD44 to mediate cisplatin resistance. Both HA and CD44 have been implicated in solid tumor progression and invasion in head and neck cancers and other cancers. This group has shown in the past that HA-CD44 can signal intracellular Ca 2þ accumulation and activation of epidermal growth factor receptor (EGFR) and subsequent oncogenic signaling in head and neck cancer. In this study this group looked at in vitro growth and cell signaling in HSC-3 head and neck cancer cells in response to HA and CD44. They show that HA through CD44 signaling activates Rho kinase and PI-3 kinase as well as Rho-kinase mediated downstream signaling which promoted migration and increased matrix metalloproteinase secretion, both of which promote invasion. This signaling also promoted tumor cell proliferation. In addition, HA treatment of the HSC-3 cells led to a 12-fold increase in cisplatin resistance. The cisplatin resistance conferred by HA could be blocked by Rho-kinase and a phosphoinositide (PI)-3-kinase inhibitors, indicating that these were the downstream mediators of resistance in response to HA. The authors conclude that blocking the HA-CD44 mediated Rho-kinase and a PI-3-kinase signaling may be a novel way to overcome cisplatin resistance in head and neck cancer. The authors reviewed 346 patients in the Veterans Administration (VA) system database with Merkel cell carcinoma of all sites (21% head and neck) to determine if there was a subgroup of patients in whom the risk of nodal metastasis would be unlikely and therefore nodal evaluation safely avoided.
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In 213 of these patients that were treated surgically, tumor size was correlated to nodal disease. Of 54 patients with tumors <1 cm, only 2 (3.7%) had nodal metastasis compared with 22% of patients with tumors between 1 and 2 cm, and 41% of patients with tumors >2 cm (p < .0001). Of the 2 patients with tumors <1 cm, both were identified on examination. Of patients with clinically negative necks, the rate of nodal metastasis on surgical staging was 0%, 5%, and 12% for tumors <1 cm, 1 to 2, and >2 cm, respectively.
In the discussion section, the authors mention that disease stage is the only predictor of survival. The 5-year survival was significantly influenced by the presence or absence of regional disease. Identification of patients with occult nodal disease is important and can be achieved by sentinel lymph node biopsy (SLNB) or neck dissection. Given the low probability of identifying occult disease in patients with tumors <1 cm, the authors suggest that these patients be observed.
A letter to the editor pointed to the flaws of this review. There was no mention of regional recurrence. The number of patients subjected to SLNB or SND was not mentioned, and neither were the pathology techniques to identified tumor in the harvested nodes. Using SLNB and immunohistochemical analysis, these physicians identified Merkel cell carcinoma in 5 of 12 patients with tumors <1 cm. Obviously, more studies are needed before nodal staging is abandoned. Conference led to publication of guidelines that provide a standardized nomenclature for interpretation of thyroid fine-needle aspirates, the Bethesda System for Reporting Thyroid Cytopathology. Each of the 6 diagnostic categories in this system has associated risks of malignancy based on literature review, which can guide clinical management.
In this study, the diagnoses of all thyroid FNAs seen at the University of Virginia from 1992 to 2009 were retrospectively reinterpreted using the Bethesda system. The overall distribution of the 3080 diagnoses and rate of malignancy for those lesions that were resected were as follows: nondiagnostic (includes cyst fluid only cases) 18.6%/8.9%, benign 59.0%/1.1%, atypia of undetermined significance/ follicular lesion of undetermined significance (AFLUS) 3.4%/17%, suspicious for follicular neoplasm 9.7%/ 25.4%, suspicious for malignancy 2.3%/ 70%, and malignant 7.0%/98%. The rates of malignancy were overall very similar to the implied risks of malignancy provided with the Bethesda System publication and reported by others.
This paper illustrates problems with the AFLUS category. The criteria for AFLUS are subjective, and there are significant differences in diagnostic frequency and rate of malignancy in this category among published studies. Limitations of this study are that it is retrospective and the slides themselves were not reviewed. Nonetheless, the different rates of malignancies found for the various categories paralleling those provided with the published guidelines suggests that the Bethesda System can provide useful information for risk stratification and guidance of clinical management of patients with thyroid nodules. This is a retrospective review of 20 patients treated for fourth branchial pouch anomalies. There were 15 girls and 5 boys. The mean age was 5.5 years (range, birth to 18 years). Four patients (all neonates) presented with a noninfected cervical mass compressing the larynx, and 16 patients (1 neonate and 15 children) presented with an infected or inflammatory lesion. Eighty-five percent of patients had a CT scan, and endoscopy confirmed the diagnosis in all cases. In 1 neonatal patient, the initial treatment was a cervical approach with resection of the lesion. In the remaining 19 patients, the initial treatment was an endoscopic approach (with cauterization, CO2 laser, or thulium laser of the tract). Patients with an infected lesion were treated with a 10-day course of amoxicillin-clavulanic acid, followed by either immediate cauterization of the pyriform fossa sinus tract versus incision and drainage of the neck abscess and delayed cauterization of the pyriform fossa sinus tract. Of the patients who were treated with an endoscopic approach, 68% were successfully treated with 1 procedure, 79% after 2 procedures, and 89% after 3 procedures (including cervical resection in 3 cases for failed endoscopic intervention). Three patients had a nasogastric tube left in place for a mean of 4.3 days. The authors concluded that fourth branchial pouch anomalies present in 2 distinct forms: a neonatal form and a childhood form. The authors recommended endoscopic control of the tract whenever possible, with repeat endoscopic techniques for recurrence in the childhood form, as opposed to the cervical approach for recurrence in the neonatal form. This is a prospective cohort study looking at children with moderate to severe drooling (teachers drooling score 3, and a nonprogressive neurologic disorder) where conservative measures were not sufficient or contraindicated. With the patient under general anesthesia, and with use of ultrasound guidance, each submandibular gland was injected in 3 sites with botulinum toxin type A (15 U per gland for patients less than 15 kg, 20 U per gland between 15 kg and 20 kg, 25 U per gland more than 25 kg). Drooling was assessed before treatment and 8 and 32 weeks after treatment. Assessment measures included the drooling quotient (DQ), caretaker visual analogue scale (VAS), and qualitative measures such as oral hygiene, saliva viscosity, feeding behavior, and speech.
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One hundred thirty-one children were analyzed (77 boys and 54 girls), with a mean age of 10.9 years (range, 3-27 years). Of the patients, 90.1% had cerebral palsy, more than 50% relied on a wheelchair for mobility, 41.2% had well-controlled epilepsy, and 14.5% had intractable epilepsy. A clinically notable response in DQ was found in 46.6% of children at 2 months. Patients who initially responded to treatment experienced relapse after a median of 22 weeks. A 2 SD reduction in VAS score was noted in 51.0% after 2 months and 26.0% after 8 months. Investigators found that 41.2% experienced thickening of saliva, whereas 12.2% experienced a reduction in saliva viscosity; 3.1% had transient swallowing difficulty, 6.1% had deteriorated feeding behavior, and 6.9% had improved feeding; 1.7% had xerostomia after 2 months, which resolved after 8 months. The authors found that 3.1% had improved oral hygiene and 3.1% improved speech, both of which disappeared at the 8-month follow-up. The authors concluded the study supports the In this review, the authors chose 76 patients identified as having extensive defects of the oral cavity. The problems associated with the ipsilateral osteocutaneous fibular reconstruction of such defects include the following: a less robust blood supply to the oft used proximal skin portion of that flap; the stiffness and lack of suppleness of that proximal skin to fill multiple ablated soft tissue contours; and the lack of bulk for very extensive, multiple zone defect. By way of literature review, the alternates and their advantages and disadvantages are noted. The purpose of this article was to more thoroughly define the approach to reconstruction of composite oromandibular defects following resection of the posterior mandible and associated surrounding soft tissue resection, using a 14-year retrospective study of 76 patient. The mean follow-up was 5.5 years, and 28 of 76 patients died during the follow-up period. The soft tissue defects were classified into 5 types, based on the number of anatomic zones involved (though these zones are never defined in the article). Seventy percent of the defects involved only 1 or 2 zones, and only 1 patient had 5 zones ablated. Reconstruction was almost uniformly done using a vertical rectus myocutaneous flap (68 of 76), with only 4 using an anterolateral thigh flap. Mean hospital stay was 18 days; 54% were on an oral diet at discharge and 60% had ''normal'' or ''near normal'' speech. Little mention is made of the
